Compugen Stock

Compugen Free Cash Flow

The Free Cash Flow (FCF) of Compugen (CGEN) as of Aug 12, 2026 is 31.33 M USD. In the previous year, Free Cash Flow (FCF) was 49.49 M USD — a change of -36.69% (lower).

Free Cash Flow

31.33 MUSD

YoY

-36.69%

Last updated:

Free Cash Flow (FCF) of Compugen is 2026 31.33 M USD. Free Cash Flow (FCF) of Compugen was 2025 49.49 M USD. It decreases by -36.69% lower compared to the previous year.
Access this data via the Eulerpool API

Compugen Stock analysis

What does Compugen do? Compugen Ltd is an Israeli biotechnology company focused on the development of therapeutics and diagnostic products. It was founded in 1993 and is headquartered in Tel Aviv. Compugen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Compugen stock

Free Cash Flow (FCF) of Compugen is 31.33 M USD in 2026.

Free Cash Flow (FCF) of Compugen changed from 49.49 M USD to 31.33 M USD, representing a -36.69% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow (FCF) Compugen since 2006 – with annual values, charts, and detailed analysis.

Free Cash Flow is the cash available after capital expenditures. It represents the cash a company can use for dividends, debt reduction, or reinvestment.

FCF = Operating Cash Flow - Capital Expenditures

Free Cash Flow (FCF)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Free Cash Flow (FCF)'s Compugen historically and in real time.

Access this data via the Eulerpool API

Cash Flow — Compugen

All Key Metrics — Compugen